Traynor Capital Management, Inc. Biogen Inc. Transaction History

Traynor Capital Management, Inc.

$1.6 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$223.92 - $287.77 $5.09 Million - $6.54 Million	-22,730 Closed	0 $0
Q3 2021 Oct 25, 2021	SELL	$282.99 - $369.05 $665,875 - $868,374	-2,353 Reduced 9.38%	22,730 $6.43 Million
Q2 2021 Jul 21, 2021	SELL	$259.0 - $414.71 $575,239 - $921,070	-2,221 Reduced 8.13%	25,083 $8.75 Million
Q1 2021 May 04, 2021	BUY	$242.95 - $284.63 $218,412 - $255,882	899 Added 3.4%	27,304 $7.64 Million
Q4 2020 Jan 14, 2021	BUY	$236.26 - $355.63 $784,383 - $1.18 Million	3,320 Added 14.38%	26,405 $6.47 Million
Q3 2020 Oct 26, 2020	SELL	$264.77 - $305.71 $118,087 - $136,346	-446 Reduced 1.9%	23,085 $6.12 Million
Q2 2020 Aug 10, 2020	BUY	$258.66 - $342.55 $1.05 Million - $1.4 Million	4,073 Added 20.93%	23,531 $6.3 Million
Q1 2020 Apr 29, 2020	BUY	$268.85 - $341.04 $790,419 - $1 Million	2,940 Added 17.8%	19,458 $6.16 Million
Q4 2019 Jan 24, 2020	SELL	$220.06 - $304.07 $46,652 - $64,462	-212 Reduced 1.27%	16,518 $4.9 Million
Q3 2019 Nov 01, 2019	SELL	$217.44 - $243.88 $66,319 - $74,383	-305 Reduced 1.79%	16,730 $3.9 Million
Q2 2019 Jul 26, 2019	BUY	$219.29 - $241.72 $651,729 - $718,391	2,972 Added 21.13%	17,035 $4.01 Million
Q1 2019 Apr 12, 2019	BUY	$216.71 - $338.96 $887,210 - $1.39 Million	4,094 Added 41.07%	14,063 $3.32 Million
Q4 2018 Jan 24, 2019	BUY	$278.5 - $352.75 $158,188 - $200,362	568 Added 6.04%	9,969 $3 Million
Q3 2018 Oct 24, 2018	BUY	$293.51 - $383.83 $98,912 - $129,350	337 Added 3.72%	9,401 $3.32 Million
Q2 2018 Aug 03, 2018	BUY	$257.52 - $306.91 $113,308 - $135,040	440 Added 5.1%	9,064 $2.68 Million
Q1 2018 May 01, 2018	BUY	$260.13 - $367.91 $457,828 - $647,521	1,760 Added 25.64%	8,624 $2.36 Million
Q4 2017 Feb 01, 2018	BUY	$307.64 - $344.58 $455,614 - $510,322	1,481 Added 27.51%	6,864 $2.19 Million
Q3 2017 Oct 27, 2017	BUY	$281.15 - $329.69 $1.51 Million - $1.77 Million	5,383	5,383 $1.67 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Traynor Capital Management, Inc. with notifications on news.

Account